Analyzing Johnson & Johnson's bankruptcy claim : good strategy or bad ethics? /

Pharma giant Johnson & Johnson announced plans in November 2021 to split its pharmaceutical and medical devices divisions and its consumer products division into two publicly traded companies. The month prior, Johnson & Johnson also created a spin-off company which immediately filed for bank...

Full description

Bibliographic Details
Main Author:	Hobbs, Allegra (Author)
Format:	eBook
Language:	English
Published:	London : SAGE Publications: SAGE Business Cases Originals, 2022.
Series:	SAGE business cases.
Subjects:	Johnson & Johnson > Case studies. Johnson & Johnson. Business ethics > Case studies. Bankruptcy > Case studies. Strategic planning > Case studies. Morale des affaires > Études de cas. Planification stratégique > Études de cas. Bankruptcy. Business ethics. Strategic planning. Electronic books. Case studies.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Pharma giant Johnson & Johnson announced plans in November 2021 to split its pharmaceutical and medical devices divisions and its consumer products division into two publicly traded companies. The month prior, Johnson & Johnson also created a spin-off company which immediately filed for bankruptcy, a savvy but ethically dubious way of sidestepping the growing number of lawsuits against the company over its role in the opioid crisis and the alleged cancer-causing agents contained in its baby powder. This case covers J&J's latest strategic maneuvers and asks students to discuss them through the lens of strategic management and ethics.
Physical Description:	1 online resource : illustrations.
ISBN:	9781529600483 1529600480